Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatments

Journal of Hepatology

Volumn 58, Issue 4, 2013, Pages 698-705

  Tryc, Anita B ^a   Goldbecker, Annemarie ^a   Berding, Georg ^a   Rümke, Stefan ^a   Afshar, Kambiz ^a   Shahrezaei, Golschan Hamidi ^a   Pflugrad, Henning ^a   Barg Hock, Hannelore ^a   Strassburg, Christian P ^a   Hecker, Hartmut ^a   Weissenborn, Karin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Keywords Parkinsonism in liver disease Hepatic myelopathy Single photon emission tomography Dopaminergic neurotransmission

Indexed keywords

2BETA CARBOMETHOXY 3 BETA ( 4 IODOPHENYL)TROPANE I 123; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; IOLOPRIDE I 123; LEVODOPA; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; MORTALITY; MOTOR DYSFUNCTION; NEUROIMAGING; NEUROLOGIC EXAMINATION; OUTPATIENT; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; TREATMENT RESPONSE; WARD;

ADULT; CORPUS STRIATUM; DOPAMINE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 84880947834     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.11.043     Document Type: Article

References (39)

1. S. Krieger, M. Jauß, O. Jansen, L. Theilmann, M. Geißler, and D. Krieger Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis Gastroenterology 111 1996 147 155 (Pubitemid 26226894)
2. M. Butz, L. Timmermann, M. Braun, S.J. Groiss, L. Wojtecki, and S. Ostrowski Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy Acta Neurol Scand 122 2010 27 35
3. W. Van Woerkem La, cirrhose hepatique avec alterations dans les centres nerveux evoluant chez des sujets d'age moyen. Nouvelle Iconographie de la Salpetriere Clinique des Maladies du Systeme Nerveux 7 1914 41 51
4. M. Victor, R.D. Adams, and M. Cole The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration Medicine (Baltimore) 44 1965 345 396
5. A. Read, S. Sherlock, and J. Laidlaw The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation Q J Med 36 1967 135 150
6. U. Patzold, P. Haller, J. Haas, P. Pocklington, and H. Deicher Therapie der Multiplen Sklerose mit Levamisol und Azathioprin Nervenarzt 49 1978 285 294
7. R.J. Martilla, and U.K. Rinne Disability and progression in Parkinson's disease Acta Neurol Scand 56 1977 159 169 (Pubitemid 8147683)
8. K. Weissenborn Psychometric tests for diagnosing minimal hepatic encephalopathy Metab Brain Dis 2012 [e-pub ahead of print]. http://dx.doi.org/ 10.1007/s11011-012-9336-4
9. H.O. Conn, C.M. Leevy, Z.R. Vlahcevic, J.B. Rodgers, W.C. Maddrey, and L. Seeff Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72 1977 573 583 (Pubitemid 8097592)
10. G. Berding, T. Brucke, P. Odin, D.J. Brooks, H. Kolbe, and P. Gielow [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy Nuklearmedizin 42 2003 31 38 (Pubitemid 36231689)
11. R. Buchert, G. Berding, F. Wilke, B. Martin, D. von Borczyskowski, and J. Mester IBZM-tool - a fully automated expert system for the evaluation of IBZM-SPECT studies Eur J Nucl Med Mol Imaging 33 2006 1073 1083 (Pubitemid 44215673)
12. K. Van Laere, A. Varrone, J. Booij, T. Vander Borght, F. Nobili, and O.L. Kapucu EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2 Eur J Nucl Med Mol Imaging 37 2010 434 442
13. J. Darcourt, J. Booij, K. Tatsch, A. Varrone, T. Vander Borght, and O.L. Kapucu EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 Eur J Nucl Med Mol Imaging 37 2010 443 450
14. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470 (Pubitemid 32119037)
15. B. Pinarbasi, S. Kaymakoglu, Z. Matur, F. Akyuz, K. Demir, and F. Besisik Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 43 2009 176 181
16. R. Fernandez-Rodriguez, A. Contreras, J.G. de Villoria, and F. Grandas Acquired hepatocerebral degeneration: clinical characteristics and MRI findings Eur J Neurol 17 2010 1463 1470
17. P.R. Burkhard, J. Delavelle, R. Du Pasquier, and L. Spahr Chronic Parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration Arch Neurol 60 2003 521 528 (Pubitemid 36427966)
18. C. Ramaker, J. Marinus, A.M. Stiggelbout, and B.J. Van Hilten Systematic evaluation of rating scales for impairment and disability in Parkinson's disease Mov Disord 17 2002 867 876 (Pubitemid 36040991)
19. J. Ferrara, and J. Jankovic Acquired hepatocerebral degeneration J Neurol 256 2009 320 332
20. A.J. Da Rocha, F.T. Braga, C.J. da Silva, A.C. Maia Jr., G.S. Mourão, and R.J. Gagliardi Reversal of Parkinsonism and Portosystemic encephalopathy following embolization of a congenital intrahepatic venous shunt: brain MR imaging and 1H spectroscopic findings AJNR 25 2004 1247 1250 (Pubitemid 39095177)
21. G. Pomier-Layrargues, L. Spahr, and R. Butterworth Increased manganese concentration in pallidum of cirrhotic patients Lancet 345 1995 735 741
22. C. Rose, R.F. Butterworth, J. Zayed, L. Normandin, K. Todd, and A. Michalak Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction Gastroenterology 117 1999 640 644 (Pubitemid 29409250)
23. H.K. Park, S.M. Kim, C.G. Choi, M.C. Lee, and S.J. Chung Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration Mov Disord 23 2008 768 770
24. L.M. Shulman, A. Minagar, and W.J. Weiner Reversal of Parkinsonism following liver transplantation Neurology 60 2003 519 (Pubitemid 36188260)
25. G. Pomier Layrargues Movement dysfunction and hepatic encephalopathy Metab Brain Dis 16 2001 27 35
26. A. Stracciari, E. Baldin, L. Cretella, L. Delaj, R. D'Alessandro, and M. Guarino Chronic acquired hepatocerebral degeneration: effects of liver transplantation on neurological manifestations Neurol Sci 32 2011 411 415
27. R.F. Butterworth, L. Spahr, S. Fontaine, and G. Pomier Layrargues Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy Metab Brain Dis 10 1995 259 267 (Pubitemid 26042535)
28. M. Bergeron, T.A. Reader, G. Pomier Layrargues, and R.F. Butterworth Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy Neurochem Res 14 1989 853 859 (Pubitemid 19274839)
29. H. Shinotoh, B.J. Snow, N.S. Chu, C.C. Huang, C.S. Lu, and C. Lee Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study Neurology 48 1997 1053 1056
30. 18F] FDOPA PET in asymptomatic welders with occupational manganese exposure Neurology 76 2011 1296 1301
31. K. Weissenborn, H. Berding, and H. Köstler Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy Metab Brain Dis 15 2000 173 178 (Pubitemid 32112939)
32. D.D. Mousseau, P. Perney, G. Pomier Layrargues, and R.F. Butterworth Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy Neurosci Lett 162 1993 192 196 (Pubitemid 23347979)
33. M.S. Jog, and A.E. Lang Chronic acquired hepatocerebral degeneration: case reports and new insights Mov Disord 10 1995 714 722 (Pubitemid 26039719)
34. M. Lunzer, I.M. James, J. Weinman, and S. Sherlock Treatment of chronic hepatic encephalopathy with levodopa Gut 15 1974 555 561
35. E. Powell, M. Pender, J. Chalk, P.J. Parkin, R. Strong, and S. Lynch Improvement in chronic hepatocerebral degeneration following liver transplantation Gastroenterology 98 1990 1079 1082 (Pubitemid 20095864)
36. S. Papapetropoulos, and C. Singer Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD) Mov Disord 20 2005 1088 1089 (Pubitemid 41419545)
37. L. Servin-Abad, A. Tzakis, R. Schiff, and A. Regev Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation Liver Transplant 12 2006 1161 1165 (Pubitemid 44063794)
38. L. Spahr, P.R. Burkhard, H. Grötzsch, and A. Hadenque Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encdephalopathy Metab Brain Dis 17 2002 399 413 (Pubitemid 36204769)
39. A. Stracciari, M. Guarino, P. Pazzaglia, G. Marchesini, and P. Pisi Acquired hepatocerebral degeneration: full recovery after liver transplantation J Neurol Neurosurg Psychiatry 70 2001 136 137 (Pubitemid 32096144)